Qualitative Evaluation of RADx-UP Projects Addressing COVID-19 Testing Disparities Among Underserved Populations.

Am J Public Health

Shelly A. Maras, Abisola Osinuga, Tara Carr, and Gaurav Dave are with the School of Medicine, University of North Carolina at Chapel Hill. Iñigo Verduzco Gallo is with the Genome Center and Center for Advancing Cancer Health Equity, University of California, Davis. Arturo Rodriguez is with the Department of Health, Wellness and Animal Services, Brownsville, TX. Erin Corriveau is with the Department of Family Medicine and Community Health, University of Kansas City, Kansas City, KS. Kelley Milligan is with Allyson Kelley and Associates PLLC, Sacramento, CA. Allyson Kelley is with Allyson Kelley and Associates PLLC, Sisters, OR.

Published: May 2024

In this article, we present findings from a May 2022 to March 2023 qualitative evaluation of Rapid Acceleration of Diagnostics-Underserved Populations (RADx-UP) projects addressing COVID-19 testing disparities among underserved populations. Interviews with academic and community partners from 13 RADx-UP projects revealed that despite the pandemic, projects were able to build trust and relationships with underserved populations. By prioritizing community voices during a public health emergency, RADx-UP projects improved health equity and pandemic preparedness in these communities, successfully conducted community-engaged research, and built long-lasting community partnerships. (. 2024;114(S5):S410-S415. https://doi.org/10.2105/AJPH.2024.307632).

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11111372PMC
http://dx.doi.org/10.2105/AJPH.2024.307632DOI Listing

Publication Analysis

Top Keywords

radx-up projects
16
underserved populations
12
qualitative evaluation
8
projects addressing
8
addressing covid-19
8
covid-19 testing
8
testing disparities
8
disparities underserved
8
projects
5
radx-up
4

Similar Publications

Scalable solutions for global health: the SalivaDirect model.

Front Cell Infect Microbiol

November 2024

SalivaDirect, Inc., New Haven, CT, United States.

The COVID-19 pandemic caught the world unprepared. Large-scale testing efforts were urgently needed, and diagnostic strategies had to rapidly evolve in response to unprecedented worldwide demand. However, the rollout of diagnostic testing and screening for SARS-CoV-2 was often impeded by logistical challenges, including regulatory delays, workforce shortages, laboratory bottlenecks, and supply chain disruptions.

View Article and Find Full Text PDF

Important questions remain about the sources of transmission of pneumococcus to older adults in the community. This is critical for understanding the potential effects of using pneumococcal conjugate vaccines (PCVs) in children and older adults. For non-institutionalized individuals, we hypothesized that the most likely source of adult-to-adult transmission is within the household.

View Article and Find Full Text PDF

Public perception regarding diagnostic sample types as well as personal experiences can influence willingness to test. As such, public preferences for specific sample type(s) should be used to inform diagnostic and surveillance testing programs to improve public health response efforts. To understand where preferences lie, we conducted an international survey regarding the sample types used for SARS-CoV-2 tests.

View Article and Find Full Text PDF

Molecular methods have improved the sensitivity of the detection of pneumococcal carriage in saliva. However, they typically require sample culture enrichment and nucleic acid extraction prior to performing the detection assay and may limit scalability for extensive surveillance of pneumococcus, particularly in low-resource settings. We evaluated the performance of a DNA-extraction-free method for the detection of pneumococcus in saliva.

View Article and Find Full Text PDF

Qualitative Evaluation of RADx-UP Projects Addressing COVID-19 Testing Disparities Among Underserved Populations.

Am J Public Health

May 2024

Shelly A. Maras, Abisola Osinuga, Tara Carr, and Gaurav Dave are with the School of Medicine, University of North Carolina at Chapel Hill. Iñigo Verduzco Gallo is with the Genome Center and Center for Advancing Cancer Health Equity, University of California, Davis. Arturo Rodriguez is with the Department of Health, Wellness and Animal Services, Brownsville, TX. Erin Corriveau is with the Department of Family Medicine and Community Health, University of Kansas City, Kansas City, KS. Kelley Milligan is with Allyson Kelley and Associates PLLC, Sacramento, CA. Allyson Kelley is with Allyson Kelley and Associates PLLC, Sisters, OR.

In this article, we present findings from a May 2022 to March 2023 qualitative evaluation of Rapid Acceleration of Diagnostics-Underserved Populations (RADx-UP) projects addressing COVID-19 testing disparities among underserved populations. Interviews with academic and community partners from 13 RADx-UP projects revealed that despite the pandemic, projects were able to build trust and relationships with underserved populations. By prioritizing community voices during a public health emergency, RADx-UP projects improved health equity and pandemic preparedness in these communities, successfully conducted community-engaged research, and built long-lasting community partnerships.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!